Patents by Inventor Changfu Xiao

Changfu Xiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230145932
    Abstract: Disclosed herein is a method of treatment of a lower respiratory tract infection caused by, e.g., coronavirus disease (COVID-19), influenza, or other virus, comprising treatment with the NK-1 receptor antagonist, tradipitant.
    Type: Application
    Filed: March 24, 2021
    Publication date: May 11, 2023
    Inventors: Mihael H. Polymeropoulos, Christos Polymeropoulos, Vasilios Polymeropoulos, Changfu Xiao
  • Publication number: 20230073637
    Abstract: The disclosure relates to improved methods of treatment of atopic dermatitis and symptoms thereof with tradipitant.
    Type: Application
    Filed: November 7, 2022
    Publication date: March 9, 2023
    Inventors: Mihael H. Polymeropoulos, Changfu Xiao, Gunther Birznieks, Andrew Heitman, Sandra Smieszek
  • Patent number: 11549147
    Abstract: The disclosure relates to improved methods of treatment of atopic dermatitis and symptoms thereof with tradipitant.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: January 10, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Mihael H. Polymeropoulos, Changfu Xiao, Gunther Birznieks, Andrew Heitman, Sandra Smieszek
  • Publication number: 20220280471
    Abstract: Embodiments of the invention relate generally to the treatment of affective disorders and, more particularly, to the treatment of affective disorders in a patient of Majority Black African ancestry.
    Type: Application
    Filed: May 26, 2022
    Publication date: September 8, 2022
    Inventors: Mihael Polymeropoulos, Christos Polymeropoulos, Changfu Xiao
  • Publication number: 20220096449
    Abstract: Disclosed herein is a method of treatment of gastroparesis and symptoms thereof, comprising treatment with the NK-1 receptor antagonist, tradipitant.
    Type: Application
    Filed: December 3, 2019
    Publication date: March 31, 2022
    Inventors: Mihael H. Polymeropoulos, Gunther Birznieks, Changfu Xiao
  • Publication number: 20210361611
    Abstract: Tasimelteon improves sleep in individuals experiencing an advance in established bedtime.
    Type: Application
    Filed: March 4, 2019
    Publication date: November 25, 2021
    Inventors: Vasilios POLYMEROPOULOS, Christos POLYMEROPOULOS, Changfu XIAO, Mihael H. POLYMEROPOULOS
  • Publication number: 20210353586
    Abstract: The invention relates generally to improving sleep, post-sleep performance, or both and, more particularly, to so improving without inducing post-sleep effects that would impair an individual's ability to operate machinery or a motor vehicle.
    Type: Application
    Filed: September 12, 2019
    Publication date: November 18, 2021
    Inventors: Mihael H Polymeropoulos, Christos Polymeropoulos, Changfu Xiao
  • Publication number: 20210062262
    Abstract: The disclosure relates to improved methods of treatment of atopic dermatitis and symptoms thereof with tradipitant.
    Type: Application
    Filed: August 30, 2018
    Publication date: March 4, 2021
    Inventors: Mihael H. Polymeropoulos, Changfu Xiao, Gunther Birznieks, Andrew Heitman, Sandra Smieszek
  • Publication number: 20210059973
    Abstract: Embodiments of the invention relate generally to the treatment of affective disorders and, more particularly, to the treatment of affective disorders in a patient of Majority Black African ancestry.
    Type: Application
    Filed: August 2, 2018
    Publication date: March 4, 2021
    Inventors: Mihael Polymeropoulos, Christos Polymeropoulos, Changfu Xiao